These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 7610751

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Results of the North American trial of piperacillin/tazobactam compared with clindamycin and gentamicin in the treatment of severe intra-abdominal infections. Investigators of the Piperacillin/Tazobactam Intra-abdominal Infection Study Group.
    Eur J Surg Suppl; 1994; (573):61-6. PubMed ID: 7524798
    [Abstract] [Full Text] [Related]

  • 3. Prospective randomized study of piperacillin/tazobactam therapy of surgically treated intra-abdominal infection. The Piperacillin/Tazobactam Intra-Abdominal Infection Study Group.
    Polk HC, Fink MP, Laverdiere M, Wilson SE, Garber GE, Barie PS, Hebert JC, Cheadle WG.
    Am Surg; 1993 Sep; 59(9):598-605. PubMed ID: 8396374
    [Abstract] [Full Text] [Related]

  • 4. Ertapenem versus piperacillin/tazobactam in the treatment of complicated intraabdominal infections: results of a double-blind, randomized comparative phase III trial.
    Solomkin JS, Yellin AE, Rotstein OD, Christou NV, Dellinger EP, Tellado JM, Malafaia O, Fernandez A, Choe KA, Carides A, Satishchandran V, Teppler H, Protocol 017 Study Group.
    Ann Surg; 2003 Feb; 237(2):235-45. PubMed ID: 12560782
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of piperacillin/tazobactam in intra-abdominal infections.
    Vestweber KH, Grundel E.
    Eur J Surg Suppl; 1994 Feb; (573):57-60. PubMed ID: 7524797
    [Abstract] [Full Text] [Related]

  • 6. Piperacillin and tazobactam versus clindamycin and gentamicin in the treatment of hospitalized women with pelvic infection. The Piperacillin/tazobactam Study Group.
    Sweet RL, Roy S, Faro S, O'Brien WF, Sanfilippo JS, Seidlin M.
    Obstet Gynecol; 1994 Feb; 83(2):280-6. PubMed ID: 8290195
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Piperacillin/tazobactam versus imipenem/cilastatin in the treatment of intra-abdominal infections.
    Niinikoski J, Havia T, Alhava E, Pääkkönen M, Miettinen P, Kivilaakso E, Haapiainen R, Matikainen M, Laitinen S.
    Surg Gynecol Obstet; 1993 Mar; 176(3):255-61. PubMed ID: 8382381
    [Abstract] [Full Text] [Related]

  • 9. Piperacillin-tazobactam pharmacokinetics in patients with intraabdominal infections.
    Jhee SS, Kern JW, Burm JP, Yellin AE, Gill MA.
    Pharmacotherapy; 1995 Mar; 15(4):472-8. PubMed ID: 7479200
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of piperacillin/tazobactam in the treatment of experimental intra-abdominal infections.
    Nord CE, Lahnborg G.
    Eur J Surg Suppl; 1994 Mar; (573):45-9. PubMed ID: 7524795
    [Abstract] [Full Text] [Related]

  • 11. Pharmacokinetics and tissue penetration of piperacillin/tazobactam with particular reference to its potential in abdominal and soft tissue infections.
    Sörgel F, Kinzig M.
    Eur J Surg Suppl; 1994 Mar; (573):39-44. PubMed ID: 7524794
    [Abstract] [Full Text] [Related]

  • 12. Population pharmacokinetics and pharmacodynamics of piperacillin/tazobactam in patients with complicated intra-abdominal infection.
    Li C, Kuti JL, Nightingale CH, Mansfield DL, Dana A, Nicolau DP.
    J Antimicrob Chemother; 2005 Aug; 56(2):388-95. PubMed ID: 16002420
    [Abstract] [Full Text] [Related]

  • 13. Outcomes of extended infusion piperacillin/tazobactam for documented Gram-negative infections.
    Patel GW, Patel N, Lat A, Trombley K, Enbawe S, Manor K, Smith R, Lodise TP.
    Diagn Microbiol Infect Dis; 2009 Jun; 64(2):236-40. PubMed ID: 19500529
    [Abstract] [Full Text] [Related]

  • 14. Ertapenem versus piperacillin-tazobactam for treatment of mixed anaerobic complicated intra-abdominal, complicated skin and skin structure, and acute pelvic infections.
    Tellado J, Woods GL, Gesser R, McCarroll K, Teppler H.
    Surg Infect (Larchmt); 2002 Jun; 3(4):303-14. PubMed ID: 12697078
    [Abstract] [Full Text] [Related]

  • 15. Clinafloxacin versus piperacillin-tazobactam in treatment of patients with severe skin and soft tissue infections.
    Siami G, Christou N, Eiseman I, Tack KJ, Severe Skin and Soft Tissue Infections Study Group.
    Antimicrob Agents Chemother; 2001 Feb; 45(2):525-31. PubMed ID: 11158750
    [Abstract] [Full Text] [Related]

  • 16. Ertapenem once a day versus piperacillin-tazobactam every 6 hours for treatment of acute pelvic infections: a prospective, multicenter, randomized, double-blind study.
    Roy S, Higareda I, Angel-Muller E, Ismail M, Hague C, Adeyi B, Woods GL, Teppler H, Protocol 023 Study Group.
    Infect Dis Obstet Gynecol; 2003 Feb; 11(1):27-37. PubMed ID: 12839630
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam.
    Sader HS, Tosin I, Sejas L, Miranda E.
    Braz J Infect Dis; 2000 Feb; 4(1):22-8. PubMed ID: 10788842
    [Abstract] [Full Text] [Related]

  • 20. Piperacillin/tazobactam in comparison with clindamycin plus gentamicin in the treatment of intra-abdominal infections.
    Shyr YM, Lui WY, Su CH, Wang LS, Liu CY.
    Zhonghua Yi Xue Za Zhi (Taipei); 1995 Aug; 56(2):102-8. PubMed ID: 7553416
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.